Net Cash Provided by (Used in) Operating Activities |
-432K |
USD |
-78.1% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
511K |
USD |
-12.5% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-80K |
USD |
+48.8% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
6.55M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
185K |
USD |
|
Q2 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
247 |
USD |
-99.9% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
388K |
USD |
-26.8% |
Q1 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
388K |
USD |
-26.8% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
42.2K |
USD |
|
Q1 2023 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2023 |
Q3 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2022 |
Q3 2023 |
Additional Paid in Capital |
0 |
USD |
|
Q3 2023 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2023 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q2 2023 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |